In the ever-evolving landscape of pharmaceutical research, achieving clinicoequity —where clinical trials reflect the diverse populations...

Understanding waivers in Diversity Action Plans (DAP) is key for pharmaceutical executives to manage clinical trial diversity...

Today, the clinical research community is dealing with a very harsh truth: the status quo is failing huge segments of the global...